M. Edward Medof

11.9k total citations · 1 hit paper
183 papers, 9.9k citations indexed

About

M. Edward Medof is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, M. Edward Medof has authored 183 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Immunology, 67 papers in Molecular Biology and 39 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in M. Edward Medof's work include Complement system in diseases (78 papers), Monoclonal and Polyclonal Antibodies Research (35 papers) and Glycosylation and Glycoproteins Research (22 papers). M. Edward Medof is often cited by papers focused on Complement system in diseases (78 papers), Monoclonal and Polyclonal Antibodies Research (35 papers) and Glycosylation and Glycoproteins Research (22 papers). M. Edward Medof collaborates with scholars based in United States, Japan and Switzerland. M. Edward Medof's co-authors include Victor Nussenzweig, Taroh Kinoshita, Feng Lin, Michael G. Strainic, Peter S. Heeger, E I Walter, Carolyn Mold, Mark L. Tykocinski, Peter N. Lalli and R Silber and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

M. Edward Medof

182 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.

1984 477 citations M. Edward Medof, Taroh Kinoshita et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by M. Edward Medof

Since Specialization

Citations

This map shows the geographic impact of M. Edward Medof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Edward Medof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Edward Medof more than expected).

Fields of papers citing papers by M. Edward Medof

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Edward Medof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Edward Medof. The network helps show where M. Edward Medof may publish in the future.

Co-authorship network of co-authors of M. Edward Medof

This figure shows the co-authorship network connecting the top 25 collaborators of M. Edward Medof. A scholar is included among the top collaborators of M. Edward Medof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Edward Medof. M. Edward Medof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CD55 Is Essential for CD103+ Dendritic Cell Tolerogenic Responses that Protect against Autoimmunity 2019 ·American Journal Of Pathology ·Michael G. Strainic, Jinbo Liu, Fengqi An, Erin Bailey, Andrew C. Esposito, Jörg Hamann, Peter S. Heeger, M. Edward Medof	12
2	T Cell Expression of C5a Receptor 2 Augments Murine Regulatory T Cell (TREG) Generation and TREG-Dependent Cardiac Allograft Survival 2018 ·The Journal of Immunology ·(unknown), (unknown), Nicholas Chun, Miguel Fribourg, Paolo Cravedi, (unknown), Trent M. Woodruff, Pragya D. Yadav, Sérgio A. Lira, M. Edward Medof, Peter S. Heeger	25
3	Antigen-presenting cell–derived complement modulates graft-versus-host disease 2012 ·Journal of Clinical Investigation ·W. H. Kwan, Daigo Hashimoto, Estela Paz‐Artal, (unknown), Melanie Greter, (unknown), M. Edward Medof, Miriam Mérad, Peter S. Heeger	51
4	IFN-γ and IL-17 Production in Experimental Autoimmune Encephalomyelitis Depends on Local APC–T Cell Complement Production 2008 ·The Journal of Immunology ·Jinbo Liu, Feng Lin, Michael G. Strainic, Fengqi An, Robert H. Miller, Cengiz Z. Altuntas, Peter S. Heeger, Vincent K. Tuohy, M. Edward Medof	88
5	Anti-C5 Antibody Treatment Ameliorates Weakness in Experimentally Acquired Myasthenia Gravis 2007 ·The Journal of Immunology ·Yuefang Zhou, Bendi Gong, Feng Lin, Russell P. Rother, M. Edward Medof, Henry J. Kaminski	70
6	Decay Accelerating Factor Can Control T Cell Differentiation into IFN-γ-Producing Effector Cells via Regulating Local C5a-Induced IL-12 Production 2007 ·The Journal of Immunology ·Peter N. Lalli, Michael G. Strainic, Feng Lin, M. Edward Medof, Peter S. Heeger	91
7	Decay-accelerating factor modulates induction of T cell immunity 2005 ·The Journal of Experimental Medicine ·Peter S. Heeger, Peter N. Lalli, Feng Lin, Anna Valujskikh, Jinbo Liu, Nasima Muqim, Yuanyuan Xu, M. Edward Medof	242
8	Respective Roles of Decay-Accelerating Factor and CD59 in Circumventing Glomerular Injury in Acute Nephrotoxic Serum Nephritis 2004 ·The Journal of Immunology ·Feng Lin, David J. Salant, Howard Meyerson, Steven N. Emancipator, B. Paul Morgan, M. Edward Medof	33
9	Decay-Accelerating Factor Deficiency Increases Susceptibility to Dextran Sulfate Sodium-Induced Colitis: Role for Complement in Inflammatory Bowel Disease 2004 ·The Journal of Immunology ·Feng Lin, David M. Spencer, Denise A. Hatala, Alan D. Levine, M. Edward Medof	55
10	Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection 2002 ·Journal of Clinical Investigation ·(unknown), Henry J. Kaminski, Bianca M. Conti‐Fine, Wei Wang, Chelliah Richmonds, M. Edward Medof	4
11	Lipid Protein Interactions: The Assembly of CD1d1 with Cellular Phospholipids Occurs in the Endoplasmic Reticulum 2002 ·The Journal of Immunology ·Aruna Dharshan De Silva, (unknown), Naoto Matsuki, Aleksandar K. Stanic, Randy R. Brutkiewicz, M. Edward Medof, Sebastian Joyce	103
12	Characterization of the Active Sites in Decay-Accelerating Factor 2001 ·The Journal of Immunology ·(unknown), Lynne M. Mitchell, Dennis E. Hourcade, M. Edward Medof	45
13	Cooperation Between Decay-Accelerating Factor and Membrane Cofactor Protein in Protecting Cells from Autologous Complement Attack 2000 ·The Journal of Immunology ·William G. Brodbeck, Carolyn Mold, John Atkinson, M. Edward Medof	64
14	Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor 1996 ·The Journal of Immunology ·William G. Brodbeck, Dianxin Liu, Jonathan Sperry, Carolyn Mold, M. Edward Medof	89
15	[43] Mammalian glycosylphosphatidylinositol-anchored proteins and intracellular precursors 1995 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Shinichi Hirose, Jansen J. Knez, M. Edward Medof	19
16	Cloning and characterization of the mouse PIG-A gene 1995 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Jianliang Yu, (unknown), John Liu, Neal S. Young, M. Edward Medof	1
17	Synthesis of aberrant decay-accelerating factor proteins by affected paroxysmal nocturnal hemoglobinuria leukocytes. 1990 ·Journal of Clinical Investigation ·(unknown), Saugata Hazra, (unknown), M. Edward Medof	32
18	Membrane-bound C4b interacts endogenously with complement receptor CR1 of human red cells. 1986 ·The Journal of Experimental Medicine ·Tsuguki Kinoshita, M. Edward Medof, Hong Khuyen Thi Pham, Victor Nussenzweig	15
19	Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. 1985 ·The Journal of Experimental Medicine ·Taroh Kinoshita, M. Edward Medof, R Silber, Victor Nussenzweig	357
20	Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. 1982 ·The Journal of Experimental Medicine ·M. Edward Medof, Kei Iida, Carolyn Mold, Victor Nussenzweig	265

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact